List of Tables
Table 1. Global Amlodipine Besylate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Amlodipine Besylate Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Amlodipine Besylate Market Competitive Situation by Manufacturers in 2024
Table 4. Global Amlodipine Besylate Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Amlodipine Besylate Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Amlodipine Besylate Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Amlodipine Besylate Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Amlodipine Besylate Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Amlodipine Besylate, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amlodipine Besylate, Product Type & Application
Table 12. Global Key Manufacturers of Amlodipine Besylate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amlodipine Besylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amlodipine Besylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Amlodipine Besylate Sales by Region (2020-2025) & (K Units)
Table 18. Global Amlodipine Besylate Sales Market Share by Region (2020-2025)
Table 19. Global Amlodipine Besylate Sales by Region (2026-2031) & (K Units)
Table 20. Global Amlodipine Besylate Sales Market Share by Region (2026-2031)
Table 21. Global Amlodipine Besylate Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Amlodipine Besylate Revenue Market Share by Region (2020-2025)
Table 23. Global Amlodipine Besylate Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Amlodipine Besylate Revenue Market Share by Region (2026-2031)
Table 25. North America Amlodipine Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Amlodipine Besylate Sales by Country (2020-2025) & (K Units)
Table 27. North America Amlodipine Besylate Sales by Country (2026-2031) & (K Units)
Table 28. North America Amlodipine Besylate Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Amlodipine Besylate Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Amlodipine Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Amlodipine Besylate Sales by Country (2020-2025) & (K Units)
Table 32. Europe Amlodipine Besylate Sales by Country (2026-2031) & (K Units)
Table 33. Europe Amlodipine Besylate Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Amlodipine Besylate Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Amlodipine Besylate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Amlodipine Besylate Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Amlodipine Besylate Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Amlodipine Besylate Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Amlodipine Besylate Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Amlodipine Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Amlodipine Besylate Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Amlodipine Besylate Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Amlodipine Besylate Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Amlodipine Besylate Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Amlodipine Besylate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Amlodipine Besylate Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Amlodipine Besylate Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Amlodipine Besylate Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Amlodipine Besylate Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Amlodipine Besylate Sales (K Units) by Type (2020-2025)
Table 51. Global Amlodipine Besylate Sales (K Units) by Type (2026-2031)
Table 52. Global Amlodipine Besylate Sales Market Share by Type (2020-2025)
Table 53. Global Amlodipine Besylate Sales Market Share by Type (2026-2031)
Table 54. Global Amlodipine Besylate Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Amlodipine Besylate Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Amlodipine Besylate Revenue Market Share by Type (2020-2025)
Table 57. Global Amlodipine Besylate Revenue Market Share by Type (2026-2031)
Table 58. Global Amlodipine Besylate Price (USD/Unit) by Type (2020-2025)
Table 59. Global Amlodipine Besylate Price (USD/Unit) by Type (2026-2031)
Table 60. Global Amlodipine Besylate Sales (K Units) by Application (2020-2025)
Table 61. Global Amlodipine Besylate Sales (K Units) by Application (2026-2031)
Table 62. Global Amlodipine Besylate Sales Market Share by Application (2020-2025)
Table 63. Global Amlodipine Besylate Sales Market Share by Application (2026-2031)
Table 64. Global Amlodipine Besylate Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Amlodipine Besylate Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Amlodipine Besylate Revenue Market Share by Application (2020-2025)
Table 67. Global Amlodipine Besylate Revenue Market Share by Application (2026-2031)
Table 68. Global Amlodipine Besylate Price (USD/Unit) by Application (2020-2025)
Table 69. Global Amlodipine Besylate Price (USD/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Amlodipine Besylate Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Mylan Company Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Mylan Amlodipine Besylate Product
Table 79. Mylan Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Company Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Dr. Reddy's Laboratories Amlodipine Besylate Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Apotex Amlodipine Besylate Product
Table 89. Apotex Recent Developments/Updates
Table 90. Teva Pharmaceutical Company Information
Table 91. Teva Pharmaceutical Description and Business Overview
Table 92. Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Teva Pharmaceutical Amlodipine Besylate Product
Table 94. Teva Pharmaceutical Recent Developments/Updates
Table 95. Cipla Company Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Cipla Amlodipine Besylate Product
Table 99. Cipla Recent Developments/Updates
Table 100. Hikma Pharmaceuticals Company Information
Table 101. Hikma Pharmaceuticals Description and Business Overview
Table 102. Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Hikma Pharmaceuticals Amlodipine Besylate Product
Table 104. Hikma Pharmaceuticals Recent Developments/Updates
Table 105. Strides Pharma Company Information
Table 106. Strides Pharma Description and Business Overview
Table 107. Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Strides Pharma Amlodipine Besylate Product
Table 109. Strides Pharma Recent Developments/Updates
Table 110. Upsher-Smith Laboratories Company Information
Table 111. Upsher-Smith Laboratories Description and Business Overview
Table 112. Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Upsher-Smith Laboratories Amlodipine Besylate Product
Table 114. Upsher-Smith Laboratories Recent Developments/Updates
Table 115. InvaGen Pharmaceuticals Company Information
Table 116. InvaGen Pharmaceuticals Description and Business Overview
Table 117. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. InvaGen Pharmaceuticals Amlodipine Besylate Product
Table 119. InvaGen Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharmaceutical Company Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Sun Pharmaceutical Amlodipine Besylate Product
Table 124. Sun Pharmaceutical Recent Developments/Updates
Table 125. Aurobindo Pharma Company Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Aurobindo Pharma Amlodipine Besylate Product
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Lupin Pharmaceuticals Company Information
Table 131. Lupin Pharmaceuticals Description and Business Overview
Table 132. Lupin Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Lupin Pharmaceuticals Amlodipine Besylate Product
Table 134. Lupin Pharmaceuticals Recent Developments/Updates
Table 135. Zydus Pharmaceuticals Company Information
Table 136. Zydus Pharmaceuticals Description and Business Overview
Table 137. Zydus Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Zydus Pharmaceuticals Amlodipine Besylate Product
Table 139. Zydus Pharmaceuticals Recent Developments/Updates
Table 140. Oxford Pharm Company Information
Table 141. Oxford Pharm Description and Business Overview
Table 142. Oxford Pharm Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Oxford Pharm Amlodipine Besylate Product
Table 144. Oxford Pharm Recent Developments/Updates
Table 145. Wockhardt Company Information
Table 146. Wockhardt Description and Business Overview
Table 147. Wockhardt Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Wockhardt Amlodipine Besylate Product
Table 149. Wockhardt Recent Developments/Updates
Table 150. Epic Pharma Company Information
Table 151. Epic Pharma Description and Business Overview
Table 152. Epic Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Epic Pharma Amlodipine Besylate Product
Table 154. Epic Pharma Recent Developments/Updates
Table 155. CR Pharmaceutical Company Information
Table 156. CR Pharmaceutical Description and Business Overview
Table 157. CR Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. CR Pharmaceutical Amlodipine Besylate Product
Table 159. CR Pharmaceutical Recent Developments/Updates
Table 160. Alkem Laboratories Company Information
Table 161. Alkem Laboratories Description and Business Overview
Table 162. Alkem Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 163. Alkem Laboratories Amlodipine Besylate Product
Table 164. Alkem Laboratories Recent Developments/Updates
Table 165. MACLEODS Company Information
Table 166. MACLEODS Description and Business Overview
Table 167. MACLEODS Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 168. MACLEODS Amlodipine Besylate Product
Table 169. MACLEODS Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Amlodipine Besylate Distributors List
Table 173. Amlodipine Besylate Customers List
Table 174. Amlodipine Besylate Market Trends
Table 175. Amlodipine Besylate Market Drivers
Table 176. Amlodipine Besylate Market Challenges
Table 177. Amlodipine Besylate Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Amlodipine Besylate
Figure 2. Global Amlodipine Besylate Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Amlodipine Besylate Market Share by Type: 2024 & 2031
Figure 4. 2.5mg Tablets Product Picture
Figure 5. 5mg Tablets Product Picture
Figure 6. 10mg Tablets Product Picture
Figure 7. Global Amlodipine Besylate Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Amlodipine Besylate Market Share by Application: 2024 & 2031
Figure 9. High Blood Pressure
Figure 10. Heart Disease
Figure 11. Global Amlodipine Besylate Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Amlodipine Besylate Market Size (2020-2031) & (US$ Million)
Figure 13. Global Amlodipine Besylate Sales (2020-2031) & (K Units)
Figure 14. Global Amlodipine Besylate Average Price (USD/Unit) & (2020-2031)
Figure 15. Amlodipine Besylate Report Years Considered
Figure 16. Amlodipine Besylate Sales Share by Manufacturers in 2024
Figure 17. Global Amlodipine Besylate Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Amlodipine Besylate Players: Market Share by Revenue in Amlodipine Besylate in 2024
Figure 19. Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Amlodipine Besylate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Amlodipine Besylate Sales Market Share by Country (2020-2031)
Figure 22. North America Amlodipine Besylate Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Amlodipine Besylate Sales Market Share by Country (2020-2031)
Figure 26. Europe Amlodipine Besylate Revenue Market Share by Country (2020-2031)
Figure 27. Germany Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Amlodipine Besylate Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Amlodipine Besylate Revenue Market Share by Region (2020-2031)
Figure 34. China Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Taiwan Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Philippines Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Amlodipine Besylate Sales Market Share by Country (2020-2031)
Figure 45. Latin America Amlodipine Besylate Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Amlodipine Besylate Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Amlodipine Besylate Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Amlodipine Besylate Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Amlodipine Besylate by Type (2020-2031)
Figure 55. Global Revenue Market Share of Amlodipine Besylate by Type (2020-2031)
Figure 56. Global Amlodipine Besylate Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Amlodipine Besylate by Application (2020-2031)
Figure 58. Global Revenue Market Share of Amlodipine Besylate by Application (2020-2031)
Figure 59. Global Amlodipine Besylate Price (USD/Unit) by Application (2020-2031)
Figure 60. Amlodipine Besylate Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
